Current Report Filing (8-k)
09 August 2022 - 6:12AM
Edgar (US Regulatory)
0001812173
false
0001812173
2022-08-08
2022-08-08
0001812173
RBOT:ClassCommonStockParValue0.0001PerShareMember
2022-08-08
2022-08-08
0001812173
RBOT:WarrantsToPurchaseOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember
2022-08-08
2022-08-08
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 8, 2022
VICARIOUS
SURGICAL INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-39384 |
|
87-2678169 |
(State or other jurisdiction of
incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
|
|
|
|
|
78 Fourth Avenue |
|
|
|
|
Waltham, Massachusetts |
|
|
|
02451 |
(Address of principal executive offices) |
|
|
|
(Zip Code) |
Registrant’s
telephone number, including area code: (617) 868-1700
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ | Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on
which registered |
Class A common stock, par
value $0.0001 per share |
|
RBOT |
|
The New York Stock Exchange |
Warrants to purchase one share of Class A common stock,
each at an exercise price of $11.50 per share |
|
RBOT WS |
|
The New York Stock Exchange |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02. |
Results of Operations and Financial Condition. |
On
August 8, 2022, Vicarious Surgical Inc. (the “Company”) issued a press release announcing its results for the second quarter
ended June 30, 2022 and providing a business update. A copy of the press release is furnished as Exhibit 99.1 hereto.
The
information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 |
Financial Statements
and Exhibits. |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
VICARIOUS SURGICAL INC. |
|
|
|
|
By: |
/s/Adam Sachs |
|
Name: |
Adam Sachs |
|
Title: |
President and Chief Executive Officer |
2
D8 (NYSE:DEH)
Historical Stock Chart
From Apr 2024 to May 2024
D8 (NYSE:DEH)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about D8 Holdings Corp (New York Stock Exchange): 0 recent articles
More Vicarious Surgical Inc. News Articles